MicroRNA Regulation for Inflammasomes in High Glucose‐Treated ARPE‐19 Cells
Open Access
- 1 January 2024
- journal article
- research article
- Published by Wiley in Journal of Ophthalmology
- Vol. 2024 (1) , 3654690
Abstract
Purpose. This study aimed to evaluate the expression of microRNAs (miRNAs) and inflammasomes in diabetes‐induced retinal cells and to determine their role in the pathogenesis of diabetic retinopathy (DR). Methods. To establish diabetes‐induced cell models, ARPE‐19 cells were treated with high glucose. The expression levels of five miRNAs (miR‐185, miR‐17, miR‐20a, miR‐15a, and miR‐15b) were measured in high glucose‐treated ARPE‐19 cells using real‐time quantitative polymerase chain reaction. Western blotting was performed to measure inflammasome expression in cellular models. miR‐17 was selected as the target miRNA, and inflammasome expression was measured following the transfection of an miR‐17 mimic into high glucose‐treated ARPE‐19 cells. Results. In high glucose‐treated ARPE‐19 cells, miRNA expression was substantially downregulated, whereas that of inflammasome components was significantly increased. Following the transfection of the miR‐17 mimic into high glucose‐treated ARPE‐19 cells, the levels of inflammasome components were significantly decreased. Conclusions. This study investigated the relationship between miRNAs and inflammasomes in diabetes‐induced cells using high glucose‐treated ARPE‐19 cells. These findings suggested that miR‐17 suppresses inflammasomes, thereby reducing the subsequent inflammatory response and indicating that miRNAs and inflammasomes could serve as new therapeutic targets for DR.Keywords
Funding Information
- Ministry of Education (NRF-2020R1F1A1048475)
This publication has 37 references indexed in Scilit:
- miR-185-5p alleviates CCI-induced neuropathic pain by repressing NLRP3 inflammasome through dual targeting MyD88 and CXCR4International Immunopharmacology, 2022
- MicroRNAs as important regulators of the NLRP3 inflammasomeProgress in Biophysics and Molecular Biology, 2020
- MiRNA as biomarker for uveitis - A systematic review of the literatureGene, 2019
- Rapid differentiation of the human RPE cell line, ARPE-19, induced by nicotinamideExperimental Eye Research, 2019
- The pathology associated with diabetic retinopathyVision Research, 2017
- MicroRNA-20a negatively regulates expression of NLRP3-inflammasome by targeting TXNIP in adjuvant-induced arthritis fibroblast-like synoviocytesJoint Bone Spine, 2016
- IRE1α Induces Thioredoxin-Interacting Protein to Activate the NLRP3 Inflammasome and Promote Programmed Cell Death under Irremediable ER StressCell Metabolism, 2012
- MicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell DevelopmentImmunity, 2010
- Foxp3-Dependent MicroRNA155 Confers Competitive Fitness to Regulatory T Cells by Targeting SOCS1 ProteinImmunity, 2009
- ARPE-19, A Human Retinal Pigment Epithelial Cell Line with Differentiated PropertiesExperimental Eye Research, 1996